3Scan, a a San Francisco, CA-based developer of knife edge scanning microscope (KESM) technology for rapid diagnostic and therapeutic discovery applications, closed a $6.67m Series A funding round.
The round was led by Lux Capital. In conjunction with funding, Josh Wolfe and Adam Gouldburn of Lux Capital have joined 3Scan’s board of directors.
The company intends to use the funds for the continued development and deployment of its technology.
Founded in 2011 and led by CEO Todd Huffman, 3Scan develops (KESM) technology which utilizes machine vision, automated serial sectioning, micromaching, and advanced optics, combined with advanced software to enable high throughput and quantified image analysis of tissues as thin as a submicron. The KESM automatically sections and images tissue samples to create high-resolution outputs, up to a terabyte per cubic centimeter.
Beyond medical pathology, the company works with academic and commercial clients to tackle difficult research and diagnostic problems with speed, precision and accuracy. Example applications include histology, neuroscience, and composite materials science.